BlackRock Group’s Mesa Laboratories MLAB Stock Holding History

BlackRock Group’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$62K	Buy	+507	New	+$63.3K	﹤0.01%	2893

Other funds holding MLAB

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock Group's MLAB Position: Q4 2016 in Review

BlackRock Group opened a new position in Mesa Laboratories (MLAB) in Q4 2016: 507 shares worth $62K. The stake represents ﹤0.01% of the portfolio and ranks #2893 among its holdings.

86 funds tracked by Wall St. Rank hold MLAB as of Q4 2016.

BlackRock Group held 507 shares of Mesa Laboratories worth $62K as of Q4 2016.
Mesa Laboratories was a new BlackRock Group position in Q4 2016.
Mesa Laboratories made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2893 holding.
86 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.